I agree that this site is using cookies. You can find further informations here.
X
Schöffski, P
248  results:
Search for persons X
?
1

57MO Impact of nirogacestat (niro) on patient-reported outc..:

Stacchiotti, S. ; Chawla, S.P. ; Chugh, R....
ESMO Open.  9 (2024)  - p. 102447 , 2024
Link: https://doi.org/10.1016/..
 
?
2

56O A phase Ia/Ib study of the MDM2-p53 antagonist brigimad..:

Schöffski, P. ; Lorusso, P. ; Yamamoto, N....
ESMO Open.  9 (2024)  - p. 102446 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Current unmet needs in locally advanced (unresectable) or m..:

Schöffski, P. ; Jones, R.L. ; Agulnik, M....
ESMO Open.  9 (2024)  7 - p. 103487 , 2024
Link: https://doi.org/10.1016/..
 
?
4

62P Updated overall survival and safety with ripretinib vs ..:

Blay, J-Y. ; Jones, R.L. ; Gelderblom, H....
ESMO Open.  9 (2024)  - p. 102452 , 2024
Link: https://doi.org/10.1016/..
 
?
5

61MO Phase Ia/Ib study of the MDM2-p53 antagonist brigimadl..:

Reichardt, P. ; Schöffski, P. ; Lorusso, P....
ESMO Open.  9 (2024)  - p. 102451 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Circulating tumor DNA analysis of the phase III VOYAGER tri..:

Serrano, C. ; Bauer, S. ; Gómez-Peregrina, D....
Annals of Oncology.  34 (2023)  7 - p. 615-625 , 2023
Link: https://doi.org/10.1016/..
 
?
7

POSB342 Time Until Definitive Deterioration (TUDD) in Patie..:

Becker, C ; Harrow, B ; Heinrich, MC...
Value in Health.  25 (2022)  1 - p. S227 , 2022
Link: https://doi.org/10.1016/..
 
?
8

P61 Health State Utility Values and Quality of Life in Pati..:

Jones, RL ; Blay, JY ; Chi, P...
Value in Health.  25 (2022)  12 - p. S14-S15 , 2022
Link: https://doi.org/10.1016/..
 
?
9

Importance and role of independent data monitoring committe..:

Schöffski, P
BMJ Open.  11 (2021)  10 - p. e047294 , 2021
Link: https://doi.org/10.1136/..
 
?
10

Corrigendum to "Clinical Presentation, Natural History, and..:

Schöffski, P. ; Timmermans, I. ; Hompes, D....
Sarcoma.  2021 (2021)  - p. 1-1 , 2021
Link: https://doi.org/10.1155/..
 
?
11

Clinical Presentation, Natural History, and Therapeutic App..:

Schöffski, P. ; Timmermans, I. ; Hompes, D....
Sarcoma.  2020 (2020)  - p. 1-9 , 2020
Link: https://doi.org/10.1155/..
 
?
12

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in..:

Cornillie, J. ; Wozniak, A. ; Li, H....
Clinical and Translational Oncology.  22 (2019)  4 - p. 546-554 , 2019
Link: https://doi.org/10.1007/..
 
?
13

European Organisation for Research and Treatment of Cancer ..:

Touati, N. ; Schöffski, P. ; Litière, S....
Clinical Oncology.  30 (2018)  7 - p. 448-454 , 2018
Link: https://doi.org/10.1016/..
 
?
14

The effect of adjuvant chemotherapy on symptom burden and q..:

Quinten, Chantal ; Kenis, C. ; Hamaker, M....
Journal of Geriatric Oncology.  9 (2018)  2 - p. 152-162 , 2018
Link: https://doi.org/10.1016/..
 
?
15

Overall survival analysis of EXAM, a phase III trial of cab..:

Schlumberger, M. ; Elisei, R. ; Müller, S....
Annals of Oncology.  28 (2017)  11 - p. 2813-2819 , 2017
Link: https://doi.org/10.1093/..
 
1-15